Intellia Therapeutics (NTLA) EBIT Margin Growth (5y) (2020 - 2026)
Intellia Therapeutics (NTLA) EBIT Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Intellia Therapeutics | 1.67 Bn | 1.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -41,856.00 |
| Mar 31, 2026 | 5,225.00 |
| Dec 31, 2025 | 21,404.00 |
| Sep 30, 2025 | -68,239.00 |
| Jun 30, 2025 | -56,905.00 |
| Mar 31, 2025 | -47,070.00 |
| Dec 31, 2024 | -78,764.00 |
| Sep 30, 2024 | -135,038.00 |
| Jun 30, 2024 | -175,162.00 |
| Mar 31, 2024 | -16,579.00 |
| Dec 31, 2023 | 756,072.00 |
| Sep 30, 2023 | -76,798.00 |
| Jun 30, 2023 | -66,613.00 |
| Mar 31, 2023 | -58,782.00 |
| Dec 31, 2022 | -44,042.00 |
| Sep 30, 2022 | -57,853.00 |
| Jun 30, 2022 | -42,995.00 |
| Mar 31, 2022 | -107,362.00 |
| Dec 31, 2021 | -43,328.00 |
| Sep 30, 2021 | -84,127.00 |